Tim Wilson

Tim Wilson is the current CEO at Epsilogen. Prior to their current position, Tim was Managing Partner at Longcross Advisers, LLP from July 2013 to April 2017. Tim has also held positions as Head of Healthcare Research at Pacific Growth Equities from January 2006 to December 2009, Senior Principal at Atlas Venture from January 2003 to December 2004, and Head of Biotechnology and European Healthcare Research at Bear Stearns Inc from January 2000 to December 2003. Tim started their career in the finance industry as a Senior Biotechnology Analyst at UBS Securities from January 1995 to December 1998 and then at Hambrecht and Quist Inc from March 1992 to October 1995. Tim's first position in the finance industry was as an Investment Executive at Rothschild Asset Management from January 1988 to December 1992.

Tim Wilson has a PhD in Molecular Biology from the University of Cambridge, and a BSc (Hons) in Biochemistry from Imperial College London.

Kevin Fitzgerald - Chief Scientific Officer, Ian Ardill - Chief Financial Officer, and Leanne Partington - Director of Product Development report to Tim Wilson.